Millennium Management
HOWL icon

Millennium Management’s Werewolf Therapeutics HOWL Stock Holding History

Millennium Management’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Sell
132,050
-108,059
-45% -$74K ﹤0.01% 5323
2025
Q4 		$152K Sell
240,109
-76,944
-24% -$93.5K ﹤0.01% 5544
2025
Q3 		$625K Sell
317,053
-379,642
-54% -$520K ﹤0.01% 4940
2025
Q2 		$759K Sell
696,695
-87,922
-11% -$90.5K ﹤0.01% 4622
2025
Q1 		$763K Buy
784,617
+188,328
+32% +$247K ﹤0.01% 4550
2024
Q4 		$883K Sell
596,289
-727,484
-55% -$1.48M ﹤0.01% 4301
2024
Q3 		$2.81M Buy
1,323,773
+213,475
+19% +$486K ﹤0.01% 3380
2024
Q2 		$2.71M Buy
1,110,298
+544,881
+96% +$2.62M ﹤0.01% 3265
2024
Q1 		$3.66M Buy
565,417
+121,058
+27% +$705K ﹤0.01% 3193
2023
Q4 		$1.72M Sell
444,359
-22,263
-5% -$56.9K ﹤0.01% 3729
2023
Q3 		$999K Sell
466,622
-392,625
-46% -$1.08M ﹤0.01% 4186
2023
Q2 		$2.62M Sell
859,247
-238,101
-22% -$670K ﹤0.01% 3245
2023
Q1 		$2.85M Buy
1,097,348
+259,046
+31% +$772K ﹤0.01% 3092
2022
Q4 		$1.72M Buy
838,302
+326,694
+64% +$855K ﹤0.01% 3692
2022
Q3 		$2.31M Buy
511,608
+262,691
+106% +$1.43M ﹤0.01% 3617
2022
Q2 		$1.02M Buy
248,917
+206,516
+487% +$942K ﹤0.01% 4345
2022
Q1 		$187K Buy
+42,401
New +$297K ﹤0.01% 5847

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's HOWL Position: Q1 2026 in Review

Millennium Management reduced its Werewolf Therapeutics (HOWL) stake by 45% in Q1 2026, selling an estimated $74K and leaving 132,050 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #5323.

Millennium Management first reported a position in HOWL in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.66M in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Millennium Management held 132,050 shares of Werewolf Therapeutics worth $110K as of Q1 2026.
  • Millennium Management sold 108,059 Werewolf Therapeutics shares in Q1 2026, an estimated $74K.
  • Werewolf Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5323 holding.
  • Millennium Management first reported a position in Werewolf Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Millennium Management's Werewolf Therapeutics position peaked at $3.66M in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.